Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C (HCV)”

2,522 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,522 results

Testing effectiveness (Phase 2)Study completedNCT00872196
What this trial is testing

A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

Who this might be right for
Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 5
Post-approval studies (Phase 4)UnknownNCT04625322
What this trial is testing

HCV Treatment Initiation During Acute Psychiatric Admission

Who this might be right for
Hepatitis C
University Health Network, Toronto 54
Not applicableEnded earlyNCT03500562
What this trial is testing

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 3
Not applicableStudy completedNCT00187473
What this trial is testing

Natural History of Hepatitis C in Patients With Normal Liver Tests

Who this might be right for
Chronic Hepatitis C
University of California, San Francisco 92
Not applicableUnknownNCT00662194
What this trial is testing

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

Who this might be right for
HIV-hepatitis Co-infectionHIV Infections
Bayside Health 40
Large-scale testing (Phase 3)Study completedNCT01258686
What this trial is testing

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

Who this might be right for
Hepatitis C
Bukwang Pharmaceutical 53
Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Large-scale testing (Phase 3)Study completedNCT00249860
What this trial is testing

Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

Who this might be right for
Hepatitis C
EMD Serono 257
Early research (Phase 1)Study completedNCT00518622
What this trial is testing

Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 40
Not applicableNot Yet RecruitingNCT07241962
What this trial is testing

Hepatitis B and C Within the Chinese Community in Milan

Who this might be right for
HBV (Hepatitis B Virus)HCV Infection
IRCCS Ospedale San Raffaele 1,000
Testing effectiveness (Phase 2)Study completedNCT00668369
What this trial is testing

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Who this might be right for
Hepatitis C Virus InfectionLiver Transplantation
Hospital Clinic of Barcelona 34
Not applicableStudy completedNCT02139722
What this trial is testing

Patient-Centered Care and Asian Americans

Who this might be right for
Hepatitis BHepatitis CLiver Disease
University of California, San Francisco 431
Testing effectiveness (Phase 2)Study completedNCT01987453
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Who this might be right for
HCV Infection
Gilead Sciences 100
Not applicableNot Yet RecruitingNCT07503288
What this trial is testing

Genotype and Subtype Mapping of the Hepatitis C Virus

Who this might be right for
Hepatitis C VirusMutation AbnormalityRNA Positive+2 more
Assistance Publique - Hôpitaux de Paris 2,500
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Post-approval studies (Phase 4)UnknownNCT03018353
What this trial is testing

Curing HCV in Incarcerated Patients

Who this might be right for
Hepatitis C, Chronic
San Francisco Department of Public Health 100
Early research (Phase 1)Study completedNCT00730431
What this trial is testing

Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 48
Testing effectiveness (Phase 2)Study completedNCT02226939
What this trial is testing

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C

Who this might be right for
Liver CirrhosisHepatitis C, Chronic
Boehringer Ingelheim 10
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Load More Results